Your Goals. Our Mission.

A 110-year history of stability, integrity, and family ownership

Driving innovation for patients

As a global leader in neurology, Merz is driven to deliver meaningful treatment options and patient experiences with XEOMIN® (incobotulintumtoxinA). XEOMIN is approved for various therapies in 67 countries worldwide and has been used by over 2.5 million patients.

To find out about other Merz products, visit